#1
#1 out of 1
business1d ago
Lilly to halve planned €2.3 billion investment in Germany, CEO tells newspaper
- Lilly will halve its planned €2.3 billion investment in Germany, directing funds to the U.S. instead.
- The German weight‑loss injections plant in Alzey will begin operations in 2027, with reduced capacity.
- Ricks said the scrapped investment could go to Pennsylvania or a new U.S. site, with Europe still in consideration.
- Germany’s cost caps in statutory health insurance helped drive the reconsideration of the investment plan.
- Over a billion euros has already been invested in the Alzey site prior to the 2027 operations start.
- Ricks emphasized that the U.S. offers the most sense for Lilly’s growth plans.
- Lilly’s decision aligns with broader shifts in multinational investment amid policy changes in Europe.
- The Alzey plant is planned to operate at a reduced scale, affecting job projections.
- No final decision has been made on the exact new site, with U.S. options under consideration.
Vote 0